First described in 1970 (1, 2) , refractory ascites remains a poorly understood complication of long-term hemodialysis. To a certain extent it is a diagnosis of exclusion, because other causes of peritoneal fluid accumulation, such as hepatic cirrhosis, congestive heart failure, pericardial constriction or tamponade, myxedema, pancreatitis, inferior vena caval obstruction, tuberculous peritonitis, and abdominal malignancy must be ruled out. Yet a certain number of patients will remain whose ascites appears to be related merely to end-stage renal disease and dialysis.
The presentation of dialysis ascites is variable, there being no truly characteristic clinical or laboratory findings (3) . Some patients develop swelling of the abdomen only, whereas others manifest signs of fluid excess elsewhere in the body; e.g., in the form of pleural effusion or peripheral edema. Cardiac or hepatic dysfunction is not usually found, but the serum protein level may be low. The ascitic fluid itself is typically high in protein content, suggesting an exudative process. The peritoneal fluid cell count, however, is normal. Microscopy of the peritoneal membrane is usually unremarkable (3), al-though it may reveal mild, chronic, inflammatory changes (4) or slight mesothelial cell proliferation (5) .
Early investigators suggested that «dialysis ascites» was associated with a grave prognosis (1, 2) . It has been speculated that abdominal distension and commonly associated psychologic depression limit food intake and that the resulting cachexia hastens these patients' ultimate demise (5) . Later reports, however, have described a response to various forms of treatment, so that a fatal outcome is not necessarily the rule (3, 4, (6) (7) (8) (9) .
The pathogenesis of «dialysis ascites» has been a subject of much debate. Early reports incriminated prior peritoneal dialysis. Subsequently, ascites was noted in patients who had never received such therapy. Overhydration appears to be a common initiating factor, and fluid overload, coupled with a propensity of uremic patients to develop serosal inflammation, may lead to fluid accumulation in the peritoneal cavity (3, 10) . Increased vascular permeability may also playa role. Finally, «dialysis ascites» may represent a number of different disease processes, each with its own, as yet unrecognized, etiologic mechanism.
So far, the mainstay of treatment has been sodium and water restriction, together with removal of excess fluid by dialytic ultrafiltration (ultrafiltration during dialysis) (3). Eknoyan et al. (10) demonstrated that the peritoneal fluid volume could be reduced by dialytic ultrafiltration, provided enough ultrafiltrate was removed from the circulation. However, it is easier to mobilize peripheral edema than ascitic fluid in these patients (3) . Furthermore, patients with dialysis ascites are notoriously prone to develop hypotension during dialytic ultrafiltration, perhaps because of the unfavourable changes in cardiovascular function induced by the tightly distended abdomen (4) . When hypotension does occur, ultrafiltration must be discontinued, and substantial volumes of intravenous fluid may be required to maintain blood pressure. As a result, removal of excess fluid is inadequate, and control of ascites is not achieved. Perhaps for this reason, isolated ultrafiltration (ultrafiltration without dialysis) (11) -which is tolerated better than dialytic ultrafiltration in general as a method of fluid removal from overhydrated patients -has been more successful in the treatment of dialysis ascites (9) . Another proposed advantage of isolated ultrafiltration concerns the osmotic balance between the ascitic fluid and plasma compartments. During hemodialysis, the urea level falls more rapidly in the blood than in the ascitic fluid. The resulting osmotic pressure gradient may promote an unwanted shift of fluid from the blood to the peritoneal cavity. Such a shift would not be expected to occur with isolated ultrafiltration, during which plasma osmolality remains constant (9) .
Paracentesis may acutely relieve abdominal swelling, but, if repeated, paracentesis may lead to protein depletion and infection, without lasting regression of the ascites. Intermittent intravenous infusion of ascitic fluid or its protein concentrate has some advocates, but seems to be at best a temporizing measure. Relatively long-term benefit has been claimed, however, from continuous reinfusion of ascitic fluid into the venous system using a LeVeen shunt (8) . Borrowing from experience in treating uremic pericarditis, some investigators have tried to treat dialysis ascites by intraperitoneal infusion of nonabsorbable steroid, with mixed results (6, 12) . It has been speculated that angiotensin may increase thirst in these patients (3) and may also increase vascular permeability, leading to exudation of protein into the peritoneal cavity (7) . In support of such a hypothesis, bilateral nephrectomy has been found to improve ascites (7) , the theoretical benefit of this treatment being the removal of the source of renin. Recently, however, we encountered several patients whose ascites developed or recurred after bilateral nephrectomy, casting doubt on the role of the kidneys in causing ascites. Moreover, laparotomy alone has also improved dialysis ascites in some patients (13) , raising further question as to the exact benefits of nephrectomy for this condition. Finally, if uremia and dialysis are important factors in the pathogenesis of ascites, one would expect ascites to resolve after successful renal transplantation. This has, in fact, often been the case (3). What can the nephrologist offer to a patient who develops dialysis ascites? He should first thoroughly search for secondary causes. Special attention should then be paid to enforcing sodium and fluid restriction, and to ensuring an adequate intake of protein and calories. At the same time an attempt should be made to remove excess fluid by ultrafiltration during dialysis. Should this prove unsuccessful, isolated ultrafiltratrion should be tried, either immediately before dialysis or between dialysis treatments. In all cases, ultrafiltration should be performed early and vigorously, before abdominal distension has become severe enough to cause hemodynamic instability and cachexia. If such conservative treatment fails, LeVeen shunting (8) or renal transplantation may become necessary. Most recently, we have found that some patients with dialysis ascites can be satisfactorily managed by maintenance peritoneal dialysis. Prolonged follow-up will be needed before the efficacy of this latest therapeutic measure can be confirmed.
